SG Americas Securities LLC Has $363,000 Stock Holdings in Iradimed Corporation (NASDAQ:IRMD)

SG Americas Securities LLC lifted its holdings in Iradimed Corporation (NASDAQ:IRMD) by 125.0% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 6,595 shares of the medical equipment provider’s stock after purchasing an additional 3,664 shares during the quarter. SG Americas Securities LLC’s holdings in Iradimed were worth $363,000 as of its most recent SEC filing.

A number of other large investors have also recently bought and sold shares of the company. Huntington National Bank raised its stake in Iradimed by 51.3% in the 3rd quarter. Huntington National Bank now owns 1,487 shares of the medical equipment provider’s stock valued at $75,000 after acquiring an additional 504 shares during the period. Gladius Capital Management LP raised its position in shares of Iradimed by 126.6% during the third quarter. Gladius Capital Management LP now owns 1,727 shares of the medical equipment provider’s stock worth $87,000 after acquiring an additional 965 shares during the last quarter. Quantbot Technologies LP raised its position in shares of Iradimed by 83.0% during the third quarter. Quantbot Technologies LP now owns 2,320 shares of the medical equipment provider’s stock worth $117,000 after acquiring an additional 1,052 shares during the last quarter. Wilmington Savings Fund Society FSB bought a new position in shares of Iradimed during the third quarter worth about $126,000. Finally, Principal Financial Group Inc. bought a new stake in Iradimed in the third quarter worth approximately $246,000. Institutional investors and hedge funds own 92.34% of the company’s stock.

Iradimed Trading Up 0.2 %

Shares of Iradimed stock opened at $59.35 on Tuesday. The business’s 50-day moving average price is $56.13 and its 200-day moving average price is $51.36. Iradimed Corporation has a 12 month low of $40.18 and a 12 month high of $61.24. The firm has a market capitalization of $751.96 million, a PE ratio of 40.65 and a beta of 0.82.

Insiders Place Their Bets

In other Iradimed news, CFO John Glenn sold 2,500 shares of Iradimed stock in a transaction on Monday, December 2nd. The stock was sold at an average price of $54.18, for a total value of $135,450.00. Following the completion of the sale, the chief financial officer now owns 4,383 shares of the company’s stock, valued at approximately $237,470.94. This trade represents a 36.32 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 37.10% of the company’s stock.

Wall Street Analyst Weigh In

Separately, StockNews.com raised Iradimed from a “buy” rating to a “strong-buy” rating in a research report on Tuesday, January 28th.

Iradimed Profile

IRadimed Corp. engages in the development, manufacture, marketing, and distribution of Magnetic Resonance Imaging compatible medical devices. It also provides a non-magnetic Intravenous infusion pump system that is specifically designed for use during MRI procedures. The company was founded by Roger Susi in July 1992 and is headquartered in Winter Springs, FL.